ARMIDA FAJARDO: Open Payments
NPI 1043934524 · PITTSBURG, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 14 payments from 10 companies in 2025. Trend: 2023 $312 · 2024 $362 · 2025 $412
Food & beverage: $390Entertainment: $21
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $74 |
| Merck Sharp & Dohme LLC | 2 | $67 |
| GENZYME CORPORATION | 1 | $64 |
| Exact Sciences Corporation | 2 | $48 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $35 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Spectrum Pharmaceuticals Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Optos, Inc. | 1 | $21 |
Products named: KEYTRUDA, AYVAKIT, Cologuard Collection Kit, ZYNLONTA, TAGRISSO, Enhertu, ROLVEDON, Polivy.
Industry payments across CA — which companies pay providers there.
